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Abstract
Colorectal cancer (CRC), also known as colon cancer, rectal cancer, or colon cancer is one of the important mortal cancers of the
gastrointestinal tract in Iran and worldwide. Interleukin 18 is one of the cytokines that causes inflammation and plays a real role in
the inhibition of CRC development and evaluation of its rate is significant in cancer patients. The purpose of the present study
was to investigate the IL-18 gene expression and its serum levels in Iranian CRC patients compared to healthy people. A total of
35 serum samples and 24 complete blood cells (CBCs) from CRC patients and as well as 20 control samples (healthy people)
were collected from Al-Zahra hospital (Isfahan city, Iran) and serum and RNA specimens were isolated for molecular and
serological investigations. The expression level of IL-18 gene and its serum level for comparison in both CRC patients and
healthy people groups were evaluated by quantitative real-time reverse transcription PCR (q-RT-PCR) technique and ELISA
assay. The comparison of IL-18 gene expression and its serum level in blood of the CRC patients and healthy people using real-
time PCR and ELISA techniques were showed that this cytokine level was increased significantly in cancer patients (p < 0.05).
According to the significant role of IL-18 as a pro-inflammatory cytokine in developing inflammation of gastrointestinal tract and
cancer and increasing of this cytokine expression in the results of our research in CRC patients compared to the control subjects,
for diagnosing or pre-screen of CRC and other cancer patients, it would be better IL-18 expression level is check in laboratories.
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Introduction
Colorectal cancer (CRC) engages the colon or the rectum and
it is the third most common cause of cancer death in different
countries especially in Iran and after lung cancer, it is also the
second cause of cancer deaths in the industrial countries
(Rafiemanesh et al. 2016; Siegel et al. 2017). It is estimated
that about one million new cases of CRC are detected world-
wide every year and nearly half a million of them die due to
the disease. Australia, New Zealand, North America, Canada,
and parts of Europe have the highest rate of CRC and Africa,
Central and South Asia, China, India, and South America are
low incidence areas (Center et al. 2009; Jemal et al. 2011;
Schreuders et al. 2015). After lung and prostate cancers, the
prevalence of CRC in Iranian men is in the third place (about
5%) and its prevalence after breast cancer in women is 5.5%
(Jemal et al. 2011; Nejadtaghi et al. 2017). The incidence of
CRC in middle-aged people (over fifty years) and especially
in men is high and in recent years the incidence of this cancer
in people under fifty years it is common (Dolatkhah et al.
2015; Keyghobadi et al. 2015; Abdifard et al. 2016).
CRC has two forms including hereditary (familial) and
sporadic which approximately 80% are sporadic and 20%
are hereditary (Center et al. 2009; Montazer Haghighi et al.
2009; Nejadtaghi et al. 2017). Risk factors for CRC are in-
cluding obesity, low intake of vegetables and fruits, inactivity
and cigarette smoking (Center et al. 2009). Biological
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treatments are one of the different therapies which can be used
for treating CRC. Human nutrition plays an important role in
the development of CRC and consumption of foods with plen-
ty of fiber, antioxidants, and omega-3 fatty acids can be help-
ful to prevent or improve the conditions of this cancer (Baena
and Salinas 2015).
Inflammation is one of the important factors that play an
important role in the production of cytokines against expan-
sion of colorectal cancer and can also improve the condition of
the patient and decrease of tumor progression by production
of interferon from T-cells and increase of interleukins 7, 18,
and 17 (Kostic et al. 2013; Nemati et al. 2015; Brennan and
Garrett 2016; Krzystek-Korpacka et al. 2017).
Interleukin 18 (IL-18) is a pro-inflammatory cytokine and
important regulator of the inherent and acquired immune re-
sponses (Ramazi et al. 2014; Nielsen et al. 2016). This cyto-
kine can play an antitumoral and tumor role in CRC by stim-
ulation of positive T cells to the production of interferon gam-
ma (IF-γ). IL-18 activates neutrophil, produces free radicals
of oxygen, and releases cytokines (Lippitz 2013; Yadav et al.
2015). IL-18 not only induces T helper cells cytokines, but
also stimulates the T cell cytokines production related to T
helper cells type I, including IL-10, IL-13, and IL-4, and along
with IL-13 and IL-4 plays an important role in inflammatory
and immune processes. IL-18 gene is located on chromosome
11 q22 and this gene is associated with a high level of immu-
noglobulin E (Gracie et al. 2003; Yadav et al. 2015;
Southcombe et al. 2015). Although IL-18 structurally related
to the IL-1, unlike IL-1 its main biological function is in-
creased by IF-γ production, T cells, and the differentiation
induction of IF-γ. Macrophages and dendritic cells are the
main sources of IL-18 (Yang et al. 2015; Hammer et al.
2018). According to the role of IL-18 as an anti-tumorigenic
cytokine, this study was aimed to comprise the IL-18 gene
expression and its serum level in CRC patients and healthy
people.
Materials and methods
Sampling and ethical approval
In this case-control study, the ethical approval was obtained on
September 20th, 2016 from the Ethical Committee and
Research Deputy of Islamic Azad University of Shahrekord
Branch, Iran. Then, the written consents it was gatheredwithin
three months and the questionnaires were filled out. In the
testimonial forms, the details of each patient included age,
sex, smoking, history of the disease, and stage of the disease
were taken from the case file. A total of 35 serum samples and
24 CBCs from CRC patients (19 men with mean age of
61.78 years and 16 female with mean age of 53.37 years)
and as well as 20 control samples (healthy people) were
collected from Al-Zahra hospital (Isfahan city, Iran). In CRC
patients, 20 people had a story of the digestive disease and 15
people without a history of the disease. A 5 mL of peripheral
blood samples from each case and control people were taken
and transferred into two CBC and normal tubes. After centri-
fugation for 20 min at 3000 g, the serum was isolated imme-
diately and the remaining complete blood samples were used
for RNA extraction. All collected samples were evaluated by
Real-Time PCR and enzyme-linked immunosorbent assay
(ELISA) techniques to determine the IL-18 gene expression
and serum level of this interleukin.
RNA isolation and cDNA synthesis
Total RNA was isolated from peripheral blood specimen of
both patients and control people using Jena Bioscience RNA
extraction kit (Jena Bioscience, Jena, Germany) according to
the manufacturer’s protocol. The quality and quantity of each
extracted RNA sample were measured by Thermo
Scientific™ NanoDrop 2000 (Wilmington, DE, USA) at a
wavelength of 260/280 nm and 1% agarose gel electrophore-
sis according to the method described by Sambrook and
Russell 2001. Then, each RNA sample (0.2 μg) was reverse
transcript to cDNA by Yekta Tajhiz Azma cDNA synthesize
kit (Yekta Tajhiz Azma, Tehran, Iran) using Oligo (dT) 18
primer according to the company’s recommendations. The
cDNA synthesize mixture was heated to 85 °C for 5 s and
then was incubated at 42 °C for 60 min, followed by heat
inactivation for 5 min at 85 °C. Each cDNA sample was sub-
jected to reverse transcriptase polymerase chain reaction (RT-
PCR) and quantitative RT-PCR (q-RT-PCR) analysis.
Conventional reverse transcriptase PCR (RT-PCR)
The specific oligonucleotide primers for amplification of IL-
18 and GAPDH (as a reference) genes were designed using
Gene Runner software version 3.05 (Hastings Software Inc.
Hastings, NY, USA) and the specificity of primer sequences
was verified using the basic local alignment search tool
(BLAST) of the National Center for Biotechnology
Information (NCBI) GenBank online database and finally
were ordered to Macrogen, Inc. (Seoul, South Korea)
(Table 1). Amplification was performed using FlexCycler2
PCRThermal Cycler (Core Life Sciences, Germany). In brief,
RT-PCR reaction was performed in a 25 μL final volume
containing dNTPs at 200 μM each, 2.5 mM of MgCl2, 0.05
unit/μL of Taq DNA polymerase (all Cinna Gene, Iran) and
1 μg of template cDNA and diffusion water. In this step, a
negative control was contained all reagents without cDNA
that replaced by equal volume of diffusion water. The PCR
conditions consisted of initial denaturing at 95 °C for 5 min,
35 cycles of 94 °C for 30 s (initial denaturation), 63 and 65 °C
at 30 s for GAPDH and IL-18 primers annealing, respectively
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and 72 °C for 30 s (extension), followed by a final extension at
72 °C for 5 min.
The electrode buffer used was TBE (10.8 g of Tris-base
89 mM, 5.5 g of boric acid 2 mM, EDTA (pH = 8.0) 4 mL
of 0.5 M EDTA (pH = 8.0) that were combined in enough
H2O and were stirred to dissolve) and 10 μL aliquots of RT-
PCR products were loaded on the 1% agarose gel electropho-
resis and a constant voltage of 80 V for 30 min was used for
product separation. Thermo Scientific GeneRuler 100 bp
DNA Ladder (San Jose, California, USA) was used as a
DNA molecular weight to determine the amplified cDNA
products for confirmation of cDNA synthesis. After ethidium
bromide staining the agarose gel was exposed to UV light and
the picture was taken by UVIdoc gel documentation system
(Uvitec, UK).
Q-real-time-PCR analysis
The expression level of IL-18 gene in CRC patients and
healthy people compared to the GAPDH gene (housekeeping
gene as a control) were measured by q-RT-PCR. The q-RT-
PCR reaction mixture was done in a final volume of 25 μL
containing 12.5 μL of 1 × SYBR-green master mix (Applied
Biosystems), 100 ng of diluted cDNA (1.5 μL), 2 μM of each
appropriate primer (1 μL), and 9 μL of infusion water. Real-
time PCR quantification was performed using 45 cycles on the
Corbet Rotor-Gene 6000 (Corbett, Australia). The thermal
cycling program was as follows: an initial denaturation at
95 °C for 2 min followed by 45 cycles of denaturation at
95 °C for 10 s, primer annealing at 61 °C for 15 s, and exten-
sion at 72 °C for 20 s. The melting temperature analysis was
also performed from 55 °C to 95 °C at a transition rate of
0.1 °C/s at the end of an amplification reaction. The relative
expression change of the target gene (IL-18) compare to the
control gene (GAPDH) was revealed by the cycle of threshold
(Ct) values using standard curve analysis and 2-ΔΔCt relative
quantitative method.
ELISA test for evaluation of IL-18 serum level
IL-18 serum levels in 40 μL of serum of CRC patients (35
samples) and healthy people serum (20 specimens) were de-
termined by IL-18 ELISA kit (Eastbiopharm Co., Germany)
according to the manufacturer’s guidelines. Standardization
was performed using a standard solvent and dilution buffer
at a concentration of 4, 8, 16, and 32 ng/L. The procedure
was Sandwich ELISA assay and IL-18 concentration in serum
samples of all wells of the plate was measured at 450 nm
wavelength by Stat Fax–2100 ELISA plate reader
(Awareness Technology, Palm City, FL).
Statistical analysis
Each experiment was repeated at least three times. The statis-
tical significance of the relative expression changes of IL-18
andGAPDH genes, and as well as IL-18 serum levels in CRC
patients compared to the healthy people were analyzed by t-
test analysis and least significant difference (LSD) multiple
comparison tests in Social Sciences software (SPSS, Inc.,
Chicago, IL, USA) version 22 followed by independent T-
test to examine the relationship and the significance of the
data. Also, all graphs were drawn with the GraphPad Prism
software (GraphPad Software, version 5.01, San Diego, CA,
USA). All data were considered at a significant level of p
value<0.05.
Results
Patient’s information
The details on the age structure, sex composition, and history
of the disease are shown in diagrams (Fig. 1).
Conventional RT-PCR assay for verification of cDNA
synthesis
The RT-PCR reaction was performed for GAPDH (reference
gene) and the IL-18 gene amplification to ensure the cDNA
synthesis was verified for all specimens. The amplified
cDNAs of both genes were investigated on 1% agarose gel
electrophoresis and fragments with a length of 105 and 185 bp
were revealed for IL-18 and GAPDH genes, respectively and
confirmed the precision of the synthesized cDNA (Fig. 2).
Table 1 The sequence of designed primers used for the q-RT-PCR reaction
Gene Primers name Sequence Annealing temperature
(°C)
Product length
(bp)
GenBank accession
number
IL-18 IL-18-F
IL-18-R
5′-GACGCATGCCCTCAATCC-3′
5′-CTAGAGCGAATGGTGCAATC-3′
65 105 XM_011542806
GAPDH GAPDH-F
GAPDH-R
5′-GGAAGGTGAAGGTCGGAGTC-3′
5′-TCAGCCTTGACGGTGCCATG-3′
63 185 NM_001289746
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Gene expression analysis
The analysis of IL-18 gene expression compared to GAPDH
gene in CRC patients and the healthy people using q-real-time
RT-PCR using T-test analysis were evaluated. The results
were showed that the expression levels of the IL-18 gene in
CRC patient was increased statistically significant compared
to the healthy people using t-test analysis (p value <0.05)
(Fig. 3).
ELISA test results
The comparison of IL-18 serum level by ELISA assay was
indicated that the level of this cytokine in the serum sample of
CRC patients was significantly increased compared to its se-
rum level in healthy people by T-test analysis (p value <0.05)
(Fig. 4).
Discussion
CRC after breast, prostate, and lung cancers is one of the most
common cancers in developing countries and related to people
nutritional status and genetically factors (Kamangar et al.
2006). Also, the high incidence of CRC in the Iranian popu-
lation has been reported (Dolatkhah et al. 2015). The statistics
in Iran indicate that half of the patients are under age 50 years
and the incidences of CRC in Iran are increasing (Malekzadeh
et al. 2009; Safaee et al. 2012; Delavari et al. 2014). An in-
flammation of the intestine plays a very important role in the
development and progression of CRC. Important agents such
as age over 50 years, alcohol consumption, history of rectum,
breast and ovarian cancers, polyps, hereditary syndromes and
inflammatory bowel, digestive diseases like familial adeno-
matous polyposis and non-polypinal adenomatous colon
(Lynch syndrome) are risk factors for CRC (Cavestro et al.
2018; Mohapatra et al. 2018). IL-18 is one of the important
cytokines as it works as an antitumoral role in CRC patients
that it interferes with the IL-12 synergistic effect and causes to
inducing of IF-γ production and thus leads the immune re-
sponse to type I of T cells (Eaton et al. 2003; Mager et al.
2016; Mojic et al. 2018). Thus, in the present work, the gene
expression and serum level of IL-18 in Iranian CRC patients
compared to the healthy people were evaluated. After the col-
lection of peripheral blood samples from each CRC patients
and control people from one hospital in Isfahan city (Iran),
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Fig. 2 The cDNA synthesis authenticity of IL-18 (left) and GAPDH
(right) in CRC patients and healthy people by RT-PCR technique on a
1% agarose gel electrophoresis (in both gels the lane M: 100-bp
molecular weight marker (Roche, Mannheim, Germany), lanes 1: nega-
tive controls (without template cDNA), and lanes 2 to 5: amplified cDNA
for IL-18 (105 bp) and GAPDH (185 bp), respectively)
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Fig. 1 Information about the age structure, sex composition, and history of the disease in CRC patients
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these specimens were used for molecular and serological in-
vestigations. The findings were showed that the IL-18 gene
expression level in CRC patient was increased statistically
significant compared to the healthy people (p < 0.05). In ad-
dition, the ELISA assay was indicated IL-18 cytokine level in
serum samples of CRC patients was more than its serum level
in healthy people.
In many studied the effects of IL-18 in cancer patients has
been studied. In the study of Bagheri et al. 2014 the expression
level of IL-6 cytokine mRNA in 51 biopsy samples of 18
patients with stomach inflammation in Chaharmahal Va
Bakhtiari province (southwestern Iran) was evaluated using
real-time PCR. They indicated that IL-18 may play an impor-
tant role in inflammatory response and progression of Th1
response to Helicobacter infection and production of clinical
outcomes. Also in the present study, increasing of genomic
and serum levels of IL-18 and its effects on Th1 pathway and
production of inflammatory cytokines in CRC patients were
observed and according to these findings IL-18 has a signifi-
cant role in cancer patients and bacterial infections. Medina
et al. 2014 indicated a possible role of IL-18, IL-18BP, and IL-
18R in the pathogenesis of epithelial ovarian carcinoma. In
different studies by Ghorbani and coworkers in Iranian people
and Zhao and colleagues in Chinese population the associa-
tion between polymorphism of interleukin 17 (IL-17F) and
IL-17A and increased susceptibility to gastric cancer
evaluated and their researches demonstrated that these inter-
leukins are genetic risk factors in the predisposition to gastric
cancer (Ghorbani et al. 2012; Zhao et al. 2016). In our study,
only the expression level of IL-18 and its serum range in CRC
patients compared to the healthy people in Isfahan city (Iran)
were examined and the relation between increases of this cy-
tokine in cancer patients was observed. In another study, the
high expression level of IL-8 in CRC cells using real-time-
PCR technique was reported. IL-8 not only provides the pro-
liferative benefits but also potentiates the metastasis of intes-
tinal cancer cells. IL-8 cells expressing significantly increase
tumors of the control cells by increasing capillary density. In
general, these findings indicated that IL-8 over-expression
reinforces tumor growth, metastasis, chemical resistance,
and angiogenesis (Ning et al. 2011). While, in the present
study, the IL-18 expression level in the people with intestinal
tumors was increased significantly. Nakanishi and colleagues
examined the effect of IL-18 and Th1 cells on inflammation.
The results of their study indicated that Th1 cells expressing
IL-18, a response to antigen and IL-2 induce IFN-γ, and cause
the further increasing of IFN-γ production after IL-18 stimu-
lation. Their findings illative the important role of IL-18 and
its synergism effects on IFN-γ production in cancer patients
like CRC (Nakanishi et al. 2010). In another study, it was
found that the serum IL-18 and vascular endothelial growth
factor (VEGF) levels were significantly higher in patients with
prostate cancer before operation with respect to healthy con-
trols (p < 0.05) and these factors may be a useful prognostic
marker in patients with prostate cancer (Nong et al. 2010).
While the findings of our study showed that IL-18 expression
and serum levels in CRC patients compared with normal
group increased significantly (p < 0.05) and can be used prob-
ably in diagnostic studies of cancer. In the recent study, IL-18
expression significantly and positively correlated with breast
cancer patients and it was suggested that IL-18 can be used as
a potential predictor marker and guidance physicians for rec-
ommendations to newer treatment (Parikh et al. 2017). While,
in the present work in Iranian CRC patients (Isfahan city),
these findings were observed.
Conclusions
Due to the findings of this study, the increase of IL-18 in the
blood of CRC patients compared to the healthy group was
observed. Also, according to the IL-18 association with induc-
ing of IFN-γ production and the progression of the cancers the
enhancement of IL-18 expression in cancer patients it can be
used as a biomarker for cancer diagnosis in the therapeutic
strategy against cancers. Therefore the evaluation of serum
and genomic expression of this cytokine for clinical tests in
cancer patients is necessary.
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Fig. 4 The comparison of IL-18 serum level in CRC patients and healthy
people by ELISA assay using T-test analysis
Fig. 3 The compression of IL-18 gene expression in CRC patients
compared to the healthy people using t-test analysis
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